4.8 (220) In stock
The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy.
Deck Review with Nevro - by Joshua Elkington - Axial
Spinal Cord Stimulator Specialist - Los Angeles, CA: LA Pain: Interventional Pain Medicine Specialist
FDA OKs Nevro's Senza SCS For Painful Diabetic Neuropathy
Boston's PINNACLE FLX; NuVasive's Modulus ALIF; Medtronic's DCB Catheter
The Senza System as a novel spinal cord stimulator – Neuro Central
Nevro notches high point with CE mark for SCS therapy
A Look Back: The One to Beat, Nevro's Growth Strategies and Challenges
HF10 Therapy Shown Effective For Variety of Pain Conditions
Nevro unveils HFX Connect in Europe, gets expanded CE mark for HFX SCS system
Nevro Announces U.S. Launch of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain
Position Statement on Spinal Cord Stimulation for Patients with Painful Diabetic Neuropathy — OHSIPP
